BioSpace News Archive

We are executing according to plan. Our lead candidate BI-1206 has shown encouraging initial data in hematological cancers, and has now also entered clinical trials in solid cancer

c-LEcta, a globally active biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully expanded its product business in the first half of 2019.

Appoints veteran VP Operations Hires high profile cannabis sommelier

The latest valveless option provides ease of use, making tube shunt surgery more convenient and efficient.

IMV Inc. announced that company management will be presenting at the following investor conferences in September

The Illinois Biotechnology Innovation Organization (iBIO) today announced the honorees of the thirteenth annual iCON Awards – the region’s most prestigious honor for life sciences educators, researchers and civic visionaries.

Seqster, the award-winning SaaS based technology platform for enabling consumer-centered health data management, today announced it appointed 9 strategic advisory board members to reinforce the company’s mission to empower organizations to optimize the health of their employees, members or patients by providing the technology to effortlessly collect, own and share all of their health data on a nationwide basis.

Themis Bioscience announced a research collaboration and exclusive license agreement with MSD for the discovery and development of undisclosed vaccine candidates using Themis’ measles virus vector-based platform.

The international medical imaging IT and cybersecurity company Sectra will publish its interim report for the period May to July 2019 on September 3, 2019.

Rocket Pharmaceuticals, Inc. announces clearance from the Spanish Agency for Medicines and Health Products to commence enrollment in the FANCOLEN-II Phase 2 registration-enabling study of RP-L102 for Fanconi Anemia in Spain.